The resurgence of platinum-based cancer chemotherapy | Nature Reviews Cancer
Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells | SpringerLink
Schematic representation of A: Mode of action of Platinum based drug... | Download Scientific Diagram
Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy - Yusoh - 2020 - ChemMedChem - Wiley Online Library
Molecular Mechanisms of Platinum Resistance in Ovarian Cancer | IntechOpen
The mechanism of action of platinum anticancer agents—what do we really know about it? - Dalton Transactions (RSC Publishing) DOI:10.1039/B918871C
Recent advances in the synthesis, stability, and activation of platinum(IV) anticancer prodrugs - ScienceDirect
IJMS | Free Full-Text | Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer
Platinum drugs and taxanes: can we overcome resistance? | Cell Death Discovery
Target-selective delivery and activation of platinum-based anticancer agents | Future Medicinal Chemistry
Cancers | Free Full-Text | Platinum Complexes in Colorectal Cancer and Other Solid Tumors
IJMS | Free Full-Text | Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
Frontiers | The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Frontiers | Cisplatin-Membrane Interactions and Their Influence on Platinum Complexes Activity and Toxicity
IJMS | Free Full-Text | Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics
Molecular mechanisms of platinum‑based chemotherapy resistance in ovarian cancer (Review)
Multiaction Platinum(IV) Prodrug Containing Thymidylate Synthase Inhibitor and Metabolic Modifier against Triple-Negative Breast Cancer | Inorganic Chemistry
Designing platinum compounds in cancer: structures and mechanisms
Under-Reported Aspects of Platinum Drug Pharmacology
Platinum containing medications: Video & Anatomy | Osmosis
Towards rational design of RAD51-targeting prodrugs: platinum IV –artesunate conjugates with enhanced cytotoxicity against BRCA-proficient ovarian and ... - Chemical Communications (RSC Publishing) DOI:10.1039/C8CC06576D
Frontiers | Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
Satraplatin - Wikipedia
Schematic representation of the mechanism of action of cisplatin and... | Download Scientific Diagram
Third row transition metals for the treatment of cancer | Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences
Platinum Complexes | SpringerLink
